Agios Pharmaceuticals, Inc.
AQVESME
thalassemia
Resolved
218days ago
Approval decision · Dec 1, 2025
What's at stake
A final FDA approval decision on AQVESME for thalassemia is expected Dec 1, 2025.
Primary source
· SEC 8-K
verified 17h ago
“the U.S. Food and Drug Administration (FDA) approved AQVESME for the treatment of anemia in adults with alpha- or beta-thalassemia.”